WILMINGTON — ChristianaCare has spun out its first commercial biotech company focused on gene-editing technology to develop new cancer treatments. CorriXR Therapeutics launched Tuesday with $5 million in seed funding […]
© 2022 Delaware Business Times
Holiday flash sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.